Literature DB >> 10716044

Blood transfusion requirements in femoral neck fracture.

D G Swain1, P G Nightingale, J V Patel.   

Abstract

The blood transfusion requirements of a consecutive series of 249 unselected patients with femoral neck fracture were studied retrospectively. A total of 339 Units of blood were transfused (a mean of 1.36 Units per patient). Blood transfusion occurred in 132 patients (53.0%), with each receiving a mean of 2.57 Units. Patients aged 80 years and above as a group were transfused significantly more blood than those aged less than 80 years: 1.64 vs 0.94 Units, X2 = 12.09, p < 0.001. Patients with intertrochanteric fractures were transfused significantly more blood than those with intracapsular fractures (1.74 vs 1.00 Units: X2 = 13.4, p < 0.001).

Entities:  

Mesh:

Year:  2000        PMID: 10716044     DOI: 10.1016/s0020-1383(99)00191-6

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  11 in total

1.  Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood?

Authors:  Sagar J Desai; Kristi S Wood; Jackie Marsh; Dianne Bryant; Hussein Abdo; Abdel-Rahman Lawendy; David W Sanders
Journal:  Can J Surg       Date:  2014-10       Impact factor: 2.089

2.  Body mass index, risk of allogeneic red blood cell transfusion, and mortality in elderly patients undergoing hip fracture surgery.

Authors:  A B Pedersen; D Cronin Fenton; M Nørgaard; N R Kristensen; B Kuno Møller; C Erikstrup
Journal:  Osteoporos Int       Date:  2016-04-21       Impact factor: 4.507

3.  Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency.

Authors:  Helen Finnamore; James Le Couteur; Mary Hickson; Mark Busbridge; Kevin Whelan; Claire L Shovlin
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

4.  The efficacy of continuous-flow cryo and cyclic compression therapy after hip fracture surgery on postoperative pain: design of a prospective, open-label, parallel, multicenter, randomized controlled, clinical trial.

Authors:  Nick C Leegwater; Peter A Nolte; Niels de Korte; Martin J Heetveld; Kees J Kalisvaart; Casper P Schönhuth; Bas Pijnenburg; Bart J Burger; Kees-Jan Ponsen; Frank W Bloemers; Andrea B Maier; Barend J van Royen
Journal:  BMC Musculoskelet Disord       Date:  2016-04-08       Impact factor: 2.362

5.  Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.

Authors:  Jinlai Lei; Binfei Zhang; Yuxuan Cong; Yan Zhuang; Xing Wei; Yahui Fu; Wei Wei; Pengfei Wang; Shiming Wen; Hai Huang; Hu Wang; Shuang Han; Shuguang Liu; Kun Zhang
Journal:  J Orthop Surg Res       Date:  2017-08-15       Impact factor: 2.359

6.  Is fast reversal and early surgery (within 24 h) in patients on warfarin medication with trochanteric hip fractures safe? A case-control study.

Authors:  Leif Mattisson; Lasse J Lapidus; Anders Enocson
Journal:  BMC Musculoskelet Disord       Date:  2018-06-26       Impact factor: 2.362

7.  Development of a Nomogram for Predicting Blood Transfusion Risk After Hemiarthroplasty for Femoral Neck Fractures in Elderly Patients.

Authors:  Ji-Qi Wang; Lu-Ying Chen; Bing-Jie Jiang; You-Ming Zhao
Journal:  Med Sci Monit       Date:  2020-02-19

8.  Comparison of Pre- and Postoperative Hemoglobin and Hematocrit Levels in Hip Arthroscopy.

Authors:  Roberto Seijas; Wenceslao Espinosa; Andrea Sallent; Xavier Cuscó; Ramón Cugat; Oscar Ares
Journal:  Open Orthop J       Date:  2015-08-31

9.  Preoperative Iron Supplementation and Restrictive Transfusion Strategy in Hip Fracture Surgery.

Authors:  Byung-Ho Yoon; Beom Seok Lee; Heejae Won; Hyung-Kook Kim; Young-Kyun Lee; Kyung-Hoi Koo
Journal:  Clin Orthop Surg       Date:  2019-08-12

10.  Intravenous Iron May Improve Outcomes in Elderly Patients With Operative Hip Fractures.

Authors:  Jamie L Engel; Joseph N Gabra; Patrick Kane; William J Kurtz
Journal:  Geriatr Orthop Surg Rehabil       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.